SPONSOR
Instituto de Investigación Biomédica de Salamanca
Total Trials
3
Recruiting
3
Phases
Phase 3, Phase 4
Conditions studied: Small Cell Lung CarcinomaMyelodysplastic SyndromesLaparoscopic Cholecystectomy Surgery
Instituto de Investigación Biomédica de Salamanca is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Small Cell Lung Carcinoma, Myelodysplastic Syndromes, Laparoscopic Cholecystectomy Surgery.
The trial portfolio spans Phase 3, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Instituto de Investigación Biomédica de Salamanca
How many clinical trials has Instituto de Investigación Biomédica de Salamanca sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Instituto de Investigación Biomédica de Salamanca, of which 3 are actively recruiting participants. These trials cover conditions including Small Cell Lung Carcinoma, Myelodysplastic Syndromes, Laparoscopic Cholecystectomy Surgery. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Instituto de Investigación Biomédica de Salamanca research focus on?
Instituto de Investigación Biomédica de Salamanca clinical trials span Small Cell Lung Carcinoma, Myelodysplastic Syndromes, Laparoscopic Cholecystectomy Surgery. The research pipeline includes Phase 3, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Instituto de Investigación Biomédica de Salamanca clinical trial?
To participate in a Instituto de Investigación Biomédica de Salamanca trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Instituto de Investigación Biomédica de Salamanca trials with current recruitment status updated daily.
Clinical Trials by Instituto de Investigación Biomédica de Salamanca
NCT07015892 Phase 3
Recruiting
Dose-Escalation Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized Trial
Small Cell Lung Carcinoma
NCT06379945
Recruiting
Unified platforM for a Better integRal Evaluation of MyeLodyspLastic Syndromes in SpAin-Strategy for Unraveling Personalized genoMic Medicine in Public heAlth System (UMBRELLA-SUMMA)
Myelodysplastic Syndromes
NCT07195331 Phase 4
Recruiting
Comparison Between Standard and Reduced Doses of Indocyanine Green in Fluorescence Cholangiography During Laparoscopic Cholecystectomy.
Laparoscopic Cholecystectomy Surgery
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology